Douros J, Suffness M
Recent Results Cancer Res. 1981;76:153-75. doi: 10.1007/978-3-642-81565-2_14.
Twenty-six new agents of natural products origin which are under preclinical development as potential antitumor agents at the National Cancer Institute are discussed with reference to their sources, structures, antitumor activity, current status, and future potential as clinically effective drugs.
讨论了美国国立癌症研究所正在进行临床前开发、作为潜在抗肿瘤药物的26种天然产物来源的新制剂，内容涉及它们的来源、结构、抗肿瘤活性、当前状况以及作为临床有效药物的未来潜力。
